Plasma catecholamine concentrations during a 72-hour aminophylline infusion in children with acute asthma
T Ishizaki1, A Minegishi, M Morishita
1Division of Clinical Pharmacology, National Medical Center, Tokyo, Japan.
Insights
Theophylline treatment for asthma exacerbations increases catecholamines like norepinephrine and epinephrine. This study found theophylline improved lung function (PEF) but didn't directly correlate with catecholamine levels.
Area of Science:
- Pharmacology
- Pediatric Asthma
- Respiratory Medicine
Background:
- Theophylline is a bronchodilator used for asthma.
- Its mechanism may involve adrenomedullary catecholamine secretion.
Purpose of the Study:
- To investigate if theophylline stimulates catecholamine release from the adrenal medulla.
- To examine the relationship between theophylline, catecholamines, and lung function in children with asthma.
Main Methods:
- Nine children with acute asthma exacerbations received a 72-hour aminophylline infusion.
- Plasma levels of theophylline, norepinephrine (NE), and epinephrine (E) were measured.
- Peak expiratory flow (PEF) was also monitored at various time points.
Main Results:
- Theophylline infusion significantly increased plasma NE and E levels compared to baseline.
- Plasma epinephrine returned towards baseline by 72 hours, while norepinephrine remained elevated.
- Peak expiratory flow (PEF) increased significantly throughout the infusion.
Conclusions:
- Theophylline administration leads to increased plasma catecholamines in children with asthma.
- While theophylline improved lung function, the improvement did not directly correlate with increased epinephrine levels.
- The study suggests a complex interaction between theophylline, catecholamines, and bronchodilation in asthma management.
Abstract:
To explore the possibility that theophylline may act through adrenomedullary secretion of catecholamines, we examined the time courses of plasma norepinephrine (NE), epinephrine (E), and theophylline concentrations and peak expiratory flow (PEF) in nine children with an acute exacerbation of asthma receiving a 72-hour constant infusion of aminophylline. These measurements were made before (baseline) and at 2, 24, 48, and 72 hours after the infusion began. Plasma theophylline concentrations were kept constant in a near midpoint therapeutic range (mean +/- SEM, 14.1 +/- 1.3 to 16.1 +/- 1.1 micrograms/ml) during the 24- to 72-hour infusion periods. Compared with the respective baseline values (383.8 +/- 56.0 and 67.6 +/- 11.8 pg/ml for NE and E), the following postinfusion plasma catecholamines reached statistically significant difference: 664.0 +/- 125.1 pg/ml for NE at 24 hours (p less than 0.05), and 214.9 +/- 57.8, 233.7 +/- 82.2, and 137.6 +/- 39.4 pg/ml for E at 2, 24, and 48 hours (p less than 0.01). Despite the fact that similar plasma theophylline concentrations were maintained, plasma E, which peaked at 24 hours after dose, returned toward the baseline at the end of infusion (99.7 +/- 24.1 pg/ml), whereas this trend was not observed for NE. The postinfusion PEF increased (p less than 0.01) in a stepwise fashion, compared with the baseline, as the infusion progressed. The change in PEF correlated significantly (p less than 0.002) with plasma theophylline concentrations but not with the increase in plasma E from the baseline. Theophylline concentrations did not correlate with the increase in plasma NE or E from the baseline.(ABSTRACT TRUNCATED AT 250 WORDS)
More Related Videos
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
05:58Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
Related Concept Videos
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Adrenergic Agonists: Therapeutic Classification
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Cardiopulmonary Resuscitation IV: Pharmacological Management
